Point72 Asset Management L.P. 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Point72 Asset Management L.P. | 56,207 0.200% |
-2,045,830 (-97.33%) |
Filing |
| 2022-10-14 9:10 pm Purchase |
2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD |
Point72 Asset Management L.P. | 2,102,037 7.300% |
2,102,037 (New Position) |
Filing |